FDA recalls 9 batches of 'contaminated' antibiotic Tazocin
published : 2 Oct 2019 at 16:10
writer: Online Reporters
The Food and Drug Administration has recalled nine batches of the antibiotic medication Tazocin after silicone oil contamination was found in numerous vials.
The FDA was alerted by Ramathibodi Hospital that Tazocin with the registration number 2cl/54 (N), by Pfizer (Thailand) Co, was contaminated.
Silicone oil or polydimethylsiloxane contamination was found in nine batches of vials of Tazocin, said Surachoke Tangwiwat, FDA deputy secretary-general.
This type of medicine is mostly used in big hospitals. Other hospitals were in the process of inspecting their stocks, said Dr Surachoke.
People should not go into panic mode, he added.
The following nine batches of Tacozin were recalled: ALI4/T1 (with the manufacturing and expiration dates 12/2018, 11/2021 respectively), ALI4/V2 (12/2018, 11/2021), ALI5/T1 (12/2018, 11/2021), ALCP/E1 (09/2018, 08/2021), ALI7/V1 (12/2018, 11/2021), ALIA/12 (12/2018, 11/2021), ALCR/E1 (09/2018, 08/2021), ALI5/V1 (12/2018, 11/2021), and ALHY/1 (12/2018, 11/2021).
Tazocin, also sold as Zosyn and under other names, is a combination medication containing the antibiotic piperacillin and the inhibitor enzyme tazobactam, according to Wikipedia.
It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
